Kosmos Energy Ltd. (KOS): what the price assumes

boothcheck covers Kosmos Energy Ltd. (KOS) but does not put one priced-in number on it: here the defensible answer is the evidence rather than a point estimate. boothcheck publishes no house fair value, target price, or buy/sell rating. Narrative composed 2026-06-27.

Generated: 2026-07-29 · Exported: 2026-08-01 · Source: https://boothcheck.com/report/KOS

Headline

FieldValue
TickerKOS
CompanyKosmos Energy Ltd.
Current price$2.44/sh
CompositionGhana 50% / Equatorial Guinea 13% / Mauritania/Senegal 9% / Gulf of America 29%

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basisrevenue-multiple
EV / sales paid3.1x
Steady-state operating margin assumed20.9%

The price sits below what even a 5%/yr revenue decline would warrant; the inversion reports a bound, not a solved growth path.

The company earns no operating profit yet; the inversion runs on the revenue multiple and an assumed steady-state margin.

Solve inputs: computed at a 7% cost of capital with 4% terminal growth over a 5-year stage, holding a 20.9% terminal operating margin (the 75th percentile of its own demonstrated operating margins) (computed at the 7% minimum rate; the CAPM rate 5.2% sits below it).

Reconcile: at the x-ray's 9.3% required return this reads ~7%/yr; the models below use their own rates.

How unusual the bet is: within-range (limited comparison data)

ReferenceValue
implied end-window share0%

Valuation X-Ray

The price is justified by relative-multiple; asset-based land below the price.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset2.96x2expensive
Earnings—0—
Relative0.88x1justifies
Growth—0—

Families that justify the price: Relative Families that call it expensive: Asset

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 5.7%); the inversion above states its own rate.

Per-Model Detail (n=3)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$0.892.74xnoFCF base $0.2B, growth -9% (input: historical growth), terminal g 0.5%, WACC 5.7%, 5yr projection
DCF Exit MultipleGrowth$2.291.06xnoExit EV/EBITDA: 29.7x / 34.7x / 39.7x (bear / base = today's held flat / bull), 5yr
Relative ValuationRelative$2.770.88xyesP/S fallback (negative EPS): Sector P/S 1.2x × TTM revenue — excluded from consensus
Simple DDMGrowth——no—
Two-Stage DDMGrowth——no—
Simple Excess ReturnAsset$0.872.80xyesReference only (book value floor): BV/sh $0.87, ROE negative
Two-Stage Excess ReturnAsset$0.783.12xyesReference only (book value with convergence): BV/sh $0.87, ROE converges to ke
Discounted Future Market CapGrowth$0.912.68xnoRev $1.4B, growth -9% (input: historical growth; tapered), Terminal P/S: 0.8x / 1.1x / 1.3x (bear / base = today's held flat / bull, cap 6x)
Peter Lynch Fair ValueRelative$0.00—noNegative/zero EPS — earnings-based value floored at $0
Margin TrajectoryGrowth——no—
Earnings Power ValueEarnings——no—
Residual IncomeAsset——no—
Graham NumberAsset——no—
EV/EBITDA RelativeRelative$0.01243.50xyesEBITDA $0.12B × sector EV/EBITDA 6.0x (excluded from median)
FCF YieldEarnings$0.01243.50xyesFCF $241.5M / Kₑ 9.3% — zero-growth perpetuity (excluded from median)
SBC-Adj FCF YieldEarnings$0.01243.50xyesSBC-adj FCF $0.22B (FCF $0.24B − SBC $0.03B) capitalized at Kₑ (excluded from median)
Ben Graham FormulaEarnings——no—
ROIC-Justified P/BAsset——no—
P/Sales SectorRelative$2.770.88xnoRevenue $1.37B × sector P/S 1.2x
PEG Fair ValueRelative——no—
Earnings YieldEarnings——no—
Funds From Operations MultipleRelative——no—
Clinical Phase NPVGrowth——no—
MertonAsset——no—
V5 Mechanical———no—

Solvency

FieldValue
Net debt$2.8b
Share count CAGR (dilution)1.9%
Burning cashno

Operating profit is negative or near zero and the company has no demonstrated through-cycle (mid-cycle) operating margin to normalize against, so years-to-repay cannot be computed honestly.

Operating profit is negative or near zero and there is no demonstrated through-cycle (mid-cycle) operating margin to normalize against, so interest coverage cannot be computed honestly.

Bullet Takeaways

Bull Case

The counterintuitive fact about Kosmos right now is that the operations are working while the stock trades like they are failing. First-quarter 2026 net production hit a record of roughly 74,800 barrels of oil equivalent per day, up about 25% from a year earlier, driven by the ramp at the Greater Tortue Ahmeyim LNG project and new wells at Jubilee in Ghana. The 10-K describes the company as having "diversified oil and gas production from assets offshore Ghana, Equatorial Guinea, Mauritania, Senegal and the Gulf of America", and that diversification is finally producing volume after years of capital sunk into building it. The market is pricing a company in trouble; the wells are pricing a company in growth.

The LNG asset is the piece that changes the shape of the business. The 10-K records that "BP Gas Marketing was selected as the buyer for the LNG offtake for GTA Phase 1, and the Tortue Phase 1 SPA was executed in February 2020 with an initial term through the end of 2033", which means the gas has a contracted buyer for years, not a spot-market guess. In the first quarter GTA produced above the floating vessel's nameplate capacity, helped by cooler seasonal water, so the project is running ahead of its design rather than behind it. A long-dated offtake contract turns a volatile commodity exposure into something closer to an annuity, and that is the asset the bull case leans on hardest.

The deleveraging plan is where the equity could re-rate if it works. Kosmos generated about $107 million of operating cash flow and roughly $14 million of free cash flow in the quarter, reduced net debt about 7% from year-end, and raised its full-year target to a 20% net-debt reduction from an original 10%. In a leveraged producer, the cash that pays down debt transfers value from lenders to shareholders dollar for dollar, because the enterprise value is fixed and the equity sits underneath the debt. If production stays at record levels and oil cooperates, every dollar of debt retired is a dollar that accrues to the thin equity layer. That is the call option the price is offering.

Bear Case

Read this through the commodity cycle and the picture darkens. Record production in the first quarter still produced a $225.6 million net loss, with derivatives the proximate cause, and trailing operating profit is negative. Peak volume is not the same as sustainable earnings, and the gap between the two is the bear's opening. An offshore producer carries a high fixed-cost base; when realized prices soften, the operating leverage that helps on the way up cuts hard on the way down. The price the market needs from this business is one where the steady-state cash margin services a debt load that does not shrink on its own.

That debt load is the structural problem, and it dwarfs the equity. Net debt sits near $2.77 billion against liquid assets of only about $130 million, and because operating profit is negative there is no honest way to compute interest coverage or a years-to-repay figure at all. The refinancing this year tells you the cost of carrying that debt is rising, not falling: the company priced $350 million of 11.25% senior secured notes due 2031 to take out cheaper notes, and leaned on a roughly $185 million equity raise in March to address commercial debt obligations. An 11.25% coupon is what a distressed borrower pays, and equity issued at a low price to service debt dilutes the very holders the deleveraging is supposed to reward. The 10-K's own debt section flags that note holders may "have the right, at their option, to require us to repurchase all of their notes" under certain events, the kind of provision that turns a financing problem into a liquidity problem quickly.

The sell side has moved decisively to this view. BofA double-downgraded to Underperform with a $1 target, citing a reduced Brent forecast and no longer seeing a clear deleveraging path, Goldman Sachs cut to Sell on debt and project risk, and Bernstein carries a $0.80 target, leaving an average one-year target near $2.16 that sits roughly at today's price. When the volume is at a record and the consensus target still lands at the current price, the message is that the production growth is already in the price and the risk is the balance sheet underneath it. A weaker oil tape or a single missed deleveraging milestone, and the equity, sitting last in line behind almost $2.9 billion of gross debt, is where the loss lands first.

Valuation

Trailing operating profit sits below the steady-state level the price assumes, so the right lens here is sales, not earnings, and on that lens the price looks low rather than high. At roughly 3.1 times revenue the multiple is depressed enough that the price sits below what even a 5% annual revenue decline would warrant, holding a through-cycle operating margin around 21% drawn from the upper end of what Kosmos has actually demonstrated. In plain terms, the equity is priced as if the business is shrinking and the debt is permanent. That is a deep-value setup, but it is deep value for a reason, and the reason is the capital structure rather than the assets.

The method families split the way they do for any distressed, leverage-heavy producer. The asset-based lens reads the price as expensive, sitting well above where book value and profitability land, because the equity claim is small relative to the assets once the debt is subtracted. The single relative-multiple read lands below the price, reflecting the low revenue multiple. There is no meaningful earnings-power or growth-DCF read, because there is no positive normalized operating profit to capitalize. That pattern, asset-value saying expensive while the revenue multiple says cheap, is the signature of a company whose enterprise is worth something but whose equity is a thin residual after the lenders are paid.

Solvency is the valuation. Net debt near $2.77 billion against about $130 million of liquid assets, with negative operating profit, means the standard coverage and years-to-repay figures cannot be computed honestly, and that absence is itself the read: this is an equity whose value is governed almost entirely by whether the debt gets paid down faster than the assets deplete. Against a cohort that includes Talos Energy and Northern Oil and Gas, Kosmos carries more leverage and more single-project concentration than a diversified shale name, which is why its revenue multiple is the lowest and its equity the most optional. The price is not paying for the oil. It is paying for the chance that the deleveraging works before the cycle turns.

Catalysts

The first-quarter 2026 print, released in early May, set the terms for the rest of the year. Production hit a record of roughly 74,800 boepd, up about 25% year over year on the GTA ramp and new Jubilee wells, and the company generated about $107 million in operating cash flow and roughly $14 million of free cash flow, even as a derivatives loss drove a $225.6 million net loss. The headline figure investors will track is deleveraging: net debt fell about 7% from year-end to roughly $2.78 billion, and management raised its full-year target to a 20% reduction from an original 10%. Whether free cash flow alone funds that target, without leaning further on equity, is the swing variable for the next two quarters.

The financing moves have been costly and are themselves catalysts. Kosmos priced $350 million of 11.25% senior secured notes due 2031 to refinance nearer-term maturities, repurchased a portion of its 7.750% notes due 2027, and completed a March equity offering that raised about $185 million toward commercial debt obligations, exiting the quarter with roughly $500 million of liquidity. Each step buys time but raises the cash interest the business must clear, so the operational ramp has to keep pace with a heavier coupon.

The analyst tape is the bearish counterweight. BofA double-downgraded to Underperform with a $1 target on a lower Brent outlook and a less clear deleveraging path, Goldman Sachs cut to Sell on debt and project risk, and Bernstein holds a $0.80 target, against an average one-year target near $2.16 that sits roughly at today's price. With the consensus target landing where the stock already trades and production already at a record, the next re-rating, up or down, will be decided by the balance sheet rather than the wells.

Peer Cohorts (Per Segment, With Filing Citations)

Ghana / Equatorial Guinea +2 more (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

Kosmos Q1 2026 results, May 2026 · Kosmos Q1 2026 earnings, May 2026 · Kosmos debt refinancing and March 2026 equity offering · BofA, Goldman Sachs, Bernstein analyst notes, 2026

View the full interactive KOS report on boothcheck